Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.42 -0.02 (-4.52%)
As of: Aug 21, 2026 · 9:36 AM EDT

Senti Biosciences Holdings (SNTI) Current Taxes (2021 - 2022)

Senti Biosciences Holdings (SNTI) posted quarterly Current Taxes of $50044.0 for Q1 2022, down 69.46% quarter-over-quarter from $163839.0 in Q4 2021.

Senti Biosciences Holdings (SNTI) Current Taxes (2021 - 2022) Analysis & Trends

Senti Biosciences Holdings' Current Taxes history runs 2 years deep, the most recent figure standing at $50044.0 for Q1 2022.

  • In Q1 2022, Current Taxes changed N/A year-over-year to $50044.0; the TTM figure through Mar 2022 stood at $50044.0 (changed N/A YoY), while the FY2021 annual figure was $163839.0, changed N/A from the prior year.
  • Current Taxes for Q1 2022 stood at $50044.0, down from $163839.0 in the prior quarter.
  • The five-year high for Current Taxes was $163839.0 in Q4 2021, with the low at $50044.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Vertex Pharmaceuticals 138.04 Bn 130.19 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.58 Bn 77.59 Bn 3.93 Bn -
3 Argenx Se 64.52 Bn 59.34 Bn 1.37 Bn 49.00 Mn
4 Moderna 56.52 Bn 51.38 Bn 52.00 Mn -
5 BeOne Medicines 42.04 Bn 36.94 Bn 1.53 Bn 76.32 Mn
6 Alnylam Pharmaceuticals 30.67 Bn 27.36 Bn 992.69 Mn -
7 Insmed 27.27 Bn 26.11 Bn 358.27 Mn -
8 BioNTech SE 27.14 Bn 8.75 Bn 668.28 Mn 76.36 Mn
9 Royalty Pharma 27.12 Bn 26.28 Bn - -
10 Senti Biosciences Holdings 13.24 Mn 13.24 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 50,044.00
Dec 31, 2021 163,839.00
Sep 30, 2021 95,349.00
Jun 30, 2021 54,165.00